To news & knowledge overview

14th International Pharma Licensing Symposium

The program features the theme of Peak Performance,  which is designed to help Business Development and M&A executives to evolve their deal-making in an ever-changing Business Development environment.

Kempen’s talk on Friday September 21st is about ‘Designing the optimal exit strategy: IPO, M&A or dual track?’ presented by Nadine Maalouf, Executive Director Corporate Finance, Life Sciences & Healthcare.



More on

Kempen Life Sciences & Healthcare

More information? Contact

Jan De Kerpel
This checkbox is mandatory
Read here how we save your data

Kempen will use your name, telephone number and/or e-mail to respond to your request or subscription.

More information can be found in our Privacy Statement Merchant Banking and Privacy Statement for Asset Management.

Upon sending this you approve that we save your information

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.